Aids

Acquired immune deficiency syndrome (AIDS) is an infectious disease caused by the human immunodeficiency virus (HIV). It was first recognized in the United States in 1981. AIDS is the advanced form of infection with the HIV virus, which may not cause recognizable disease for a long period after the initial exposure (latency). No vaccine is currently available to prevent HIV infection.

Aids - most related articles:

- New approach to treat HIV, AIDS - 3.7
- WHO's new HIV AIDS guide - 3.6
- Indian doctors can't deny HIV+, AIDS patients - 3.5
- Boosting ranks of black HIV/AIDS researchers in US - 3.5
- Dr. Ramadoss to Mexico to attend AIDS Conference - 3.4
- India to develop HIV AIDS vaccine soon - 3.3
- $1.79 billion to help people living with HIV AIDS - 3.3
- HIV infections and AIDS related cases reduced - 3.3
- 109 medicines, vaccines in development for HIV AIDS - 3.1
- HIV cases reduced in New Zealand - 3.1

Aids articles

New drug targets aimed at slowing progression of HIV AIDS
Researchers reveal a mechanism by which the immune system tries to halt the spread of HIV. Harnessing this mechanism may open up new paths for therapeutic research aimed at slowing the virus' progression to AIDS.

Investments for children must be at top of African HIV and AIDS agenda - UNICEF
All children, particularly the poorest and most marginalized, should have access to HIV/AIDS prevention, treatment and care. Against the background of reduced funding for HIV/AIDS activities, partners and decision makers must sustain their contributions to make this world HIV free.

Many US people do not know they have HIV
An estimated 1.2 million people are living with HIV in the United States. Of those, as many as 1 in 5 people (about 240,000) don't know they have HIV.

HIV infections and AIDS related cases reduced
New HIV infections and AIDS-related deaths have fallen to the lowest levels since the peak of the epidemic. New HIV infections were reduced by 21% since 1997, and deaths from AIDS-related illnesses decreased by 21% since 2005.

Hormonal contraception doubles HIV risk in Africa
Women using hormonal contraception -- such as a birth control pill or a shot like Depo-Provera – are at double the risk of acquiring HIV, and HIV-infected women who use hormonal contraception have twice the risk of transmitting the virus to their HIV-uninfected male partners.

Odds for detecting HIV varies by method
The odds for effectively detecting HIV in African-American men vary by method, researchers have found in a recent study, which appears in the Annals of Behavioral Medicine.

HIV and AIDS cases increasing among young black gay men in US
While blacks represent 14 percent of the U.S. population, they accounted for 44 percent of new HIV infections in 2009. HIV infection rates among blacks were nearly eight times higher than rates in whites.

Marked reduction of HIV among circumcised adult men
Researchers presenting late breaking research on the final day of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) have focussed on new studies in the field of circumcision, pre-exposure prophylaxis (PrEP) and antiretroviral treatment. The IAS 2011 conference has been attended by over 5000 researchers, clinicians and community leaders since Sunday in Rome.

New drug development program for children with HIV AIDS
The Drugs for Neglected Diseases initiative (DNDi) announced the launch of a new drug development programme to address critical unmet treatment needs of children with HIV/AIDS. Because HIV transmission in young children has largely been eliminated in high-income countries due to effective prevention of mother-to-child transmission (PMTCT) interventions, little market incentive exists for pharmaceutical companies to develop antiretroviral (ARV) drugs adapted for children.

Roll out treatment as prevention now to stop HIV and AIDS
The Lancet, a leading global medical journal, published an editorial comment today that emphasizes the critical role of expanding access to HIV treatment under a "Treatment as Prevention" strategy to stop the HIV pandemic.

HIV drugs may cause premature aging
Researchers revealed that a class of anti-retroviral drugs (NRTIs) commonly used to treat HIV can cause premature ageing, as the drugs damage DNA in the patient's mitochondria. HIV-infected people treated with antiretroviral drugs sometimes show advanced signs of frailty and age-associated diseases such as cardiovascular disease and dementia at an early age.

HAART found effective for treating HIV infected children
This observational cohort study, by Andrew Edmonds and colleagues, reports that treatment with highly active antiretroviral therapy (HAART) markedly improves the survival of HIV-infected children in Kinshasa, DRC, a resource-deprived setting. The findings presented suggest that HAART is as effective for improving the survival of HIV-infected children in a severely resource-deprived country (still recovering from civil war) as in more resource-privileged settings.

Developing possibility of a preventive vaccine against HIV AIDS
The HIV epidemic is the largest in the world and represents one of the most serious public health problems, according to data from the World Health Organization (WHO). Only 30% of the more than 10 million patients in need have the access to the antiretroviral treatment.

Antiretrovirals significantly reduces HIV transmission to partners
Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by taking oral antiretroviral medicines when their immune systems were relatively healthy, according to findings from a large-scale clinical study.

HIV rates declined in Zimbabwe driven by fear of infection
The big drop in the numbers of people infected with HIV in Zimbabwe is because of mass social change, driven by fear of infection, according to an international study reported in the journal PLoS Medicine.

Stroke rate rises in HIV patients
While the overall hospitalization rate for stroke has declined in recent years, the numbers have jumped dramatically for patients infected with human immunodeficiency virus (HIV), suggesting they may be up to three times more likely to suffer a stroke than people uninfected by the virus that causes AIDS.

HIV screening cost effective in reducing spread of AIDS
An expanded U.S. program of HIV screening and treatment could prevent as many as 212,000 new infections over the next 20 years and prove to be very cost-effective, according to a new study by Stanford University School of Medicine researchers.

HIV virus hides in the brain
Studies of the spinal fluid of patients given anti-HIV drugs have resulted in new findings suggesting that the brain can act as a hiding place for the HIV virus.

New research to drive novel ways of treating and preventing HIV
The unwillingness of the global AIDS community to accept the status quo is fuelling a new era of scientific innovation to drive novel ways of treating and preventing HIV, organizers of the XVIII International AIDS Conference (AIDS 2010) taking place in Vienna, Austria said today.

Fellowships for outstanding research in drug use and HIV
The International AIDS Society (IAS) and the National Institute on Drug Abuse (NIDA) today announced the recipients of their second annual joint research fellowships. Recipients of the prestigious awards will receive US$75,000 each to advance the scientific understanding of the linkage between illicit drug use and HIV, while fostering multinational research.

Antibodies can stop most HIV strains from infecting human cells
Scientists have discovered two potent human antibodies that can stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory, and have demonstrated how one of these disease-fighting proteins accomplishes this feat.

Pregnancy doubles HIV risk in men
A new study finds that pregnancy is a time when men are at greater risk. In fact, their risk doubles if their partner is both HIV-infected and pregnant.

Chemical in banana a potent inhibitor of HIV infection
A potent new inhibitor of HIV, derived from bananas, may open the door to new treatments to prevent sexual transmission of HIV, according to a University of Michigan Medical School study published this week.

Clinic based HIV prevention is effective in reducing risk behaviors
Delivering HIV prevention services to people living with HIV in clinical settings can sharply reduce their sexual risk behaviors, revealed by UCSF researchers.

Bone marrow can harbor HIV infected cells
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. This indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.

Pneumococcal vaccine offers protection to HIV infected
A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa.

Safety concern for HIV drug combination
The U.S. Food and Drug Administration announced preliminary data suggesting that Invirase (saquinavir) in combination with Norvir (ritonavir) may have potentially important adverse effects on the heart.

Circumcised men are less likely to become HIV infected
Circumcision, which substantially lowers HIV risk in men, also dramatically changes the bacterial communities of the penis, according to a study led by scientists at the Translational Genomics Research Institute (TGen) and Johns Hopkins University and published Jan. 6 in the scientific journal PLoS ONE.

Routine HIV screening in community boosts HIV testing
UCSF researchers have that found routinely offering rapid HIV tests to patients in community health centers can significantly increase the number of patients screened for HIV.

PRO 2000 anti HIV gel is ineffective
Pro 2000, a vaginal microbicide gel designed to reduce women's risk of HIV infection, showed no evidence that it reduces the risk of HIV infection, revealed by researchers at Britain's Medical Research Council (MRC).

Red Ribbon Express launched on World Aids Day
Smt. Sonia Gandhi, Chairperson UPA and Chairperson Rajiv Gandhi Foundation flagged off the Red Ribbon Express from Safdarjung Railway Station to commemorate the World AIDS Day.

HIV vaccine failure probably caused by adenovirus
The recent failure of an HIV vaccine was probably caused by the immune system reacting to the virus 'shell' used to transmit the therapy around the body, revealed by researchers.

Ryan White HIV AIDS program extended
The U.S. Congress has extended the Ryan White HIV/AIDS Program, helping to ensure that more than half a million low-income, uninsured, or underinsured people living with HIV/AIDS have access to lifesaving care.

New HIV vaccine safe and effective in preventing HIV infection
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand.

High HIV infection rate among Soweto Township gays
New research from UCSF examining HIV among men (MSM) in the township of Soweto in South Africa has found that a third of gay-identified men are infected with HIV.

Prechewed food could transmit HIV
Researchers have uncovered the first cases in which HIV almost certainly was transmitted from mothers or other caregivers to children through pre-chewed food.

GSK to fight HIV AIDS in Africa
GlaxoSmithKline's CEO Andrew Witty announced a series of new initiatives targeted at improving research, development, and access to HIV/AIDS medicines for children in Sub-Saharan Africa and supporting healthcare for people living with HIV and AIDS.

HIV progresses faster in women than in men
One of the continuing mysteries of the HIV/AIDS epidemic is why women usually develop lower viral levels than men following acute HIV-1 infection but progress faster to AIDS than men with similar viral loads.

AIDS virus damages gut antibody-producing immune cells
A new research from the NIAID-funded Center for HIV/AIDS Vaccine Immunology suggests that HIV-1 is anything but – moving at breathtaking speed in destroying and dysregulating the body's gut-based B-cell antibody-producing system.

Combined antiviral and chemotherapy to fight HIV AIDS
HIV-AIDS could be treated through a combination of targeted chemotherapy and current Highly Active Retroviral (HAART) treatments, revealed by researchers.

South Africa's HIV epidemic has stabilised
South Africa's HIV epidemic has levelled off at a prevalence of 10.9% for people aged two years and older, with 5.2 million people estimated to be living with HIV in 2008.

Blair Underwood to Kick off AHF's US HIV Testing Caravan
In an effort to boost AIDS awareness and HIV prevention and testing efforts in some of the hardest hit regions of the United States, AIDS Healthcare Foundation (AHF) will kick off a three week, fourteen-city cross country HIV testing tour in one of its popular AHF/Magic Johnson Mobile HIV Testing Units.

AIDS Action observes HIV vaccine awareness day
Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone.

$1.79 billion to help people living with HIV AIDS
The U.S. Department of Health and Human Services (HHS) announced the release of $1.79 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications.

HIV vaccine by using gene transfer technology
A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers.

AIDS patients get benefit from early retroviral use
HIV-positive patients who don't seek medical attention until they have a serious AIDS-related condition can reduce their risk of death or other complications by half if they get antiretroviral treatment early on, according to a new multicenter trial led by researchers at the Stanford University School of Medicine.

Herpes medication does not reduce HIV transmission risk
A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.

Make this world malaria free
Progress has been made in combating malaria, particularly in Africa where the disease is most prevalent, but more must be done to address the global scourge, UNICEF said, as it released a new joint report on the eve of World Malaria Day.

Zambian success in fight against malaria
Malaria deaths reported from health facilities in Zambia have declined by 66%. This result along with other supporting data indicates that Zambia has reached the 2010 Roll Back Malaria target of a more than 50% reduction in malaria mortality compared to 2000.

Pain relievers seem not to prevent Alzheimer's disease
A new study shows that nonsteroidal anti-inflammatory drugs (NSAIDs) such as the pain relievers ibuprofen and naproxen do not prevent Alzheimer's disease, but they may instead delay its onset.

GSK and Pfizer to create a new HIV company
GlaxoSmithKline plc (GSK) and Pfizer Inc (PFE) announced they have entered into an agreement to create a new world-leading HIV company focused solely on research, development and commercialisation of HIV medicines.

Treating HIV earlier is better
Begin treatment as early as possible: this general common sense rule seems to apply to most diseases except HIV-AIDS, which is only treated once a certain number of immune cells called "CD4+" cells have disappeared.

Male circumcision surely reduces HIV risk
Three recent African trials support male circumcision for reducing the risk of contracting HIV in heterosexual men.

Nadja Benaissa arrested on suspicion of infecting a partner with HIV
Nadja Benaissa - a German pop star singer - was held in Frankfurt because of the suspicion that she had unprotected sexual intercourse with three people in the years 2004 and 2006 without telling them beforehand that she is HIV positive.

Strides received US FDA approval for Lamivudine and Stavudine
Strides Arcolab Limited (Strides) announced that it has received tentative approval from the United States – Food and Drug Administration for one new drug application (NDA) for fixed dose combination of Lamivudine and Stavudine Tablets 150 mg / 30 mg under the expedited review provisions of the President's Emergency Plan for AIDS Relief (PEPFAR).

US AIDS Relief program PEPFAR saved a million lives
PEPFAR, which the Bush administration initially established as a five-year, $15 billion plan, has kept people alive by effectively providing funds for AIDS treatment and care, according to a study from the Stanford University School of Medicine.

Boosting ranks of black HIV/AIDS researchers in US
About 500,000 African Americans are now living with HIV/AIDS. Yet there are very few African American HIV/AIDS researchers, due to historical, social and other factors that prevent them from training in the biomedical, behavioral and social aspects of HIV/AIDS research.

Education slowing HIV AIDS in sub-Saharan Africa
Increased schooling across sub-Saharan Africa may be lowering new HIV infections among younger adults, according to sociologists, suggesting a shift in a decades-long trend where formal education is considered an AIDS risk factor.

$60 m for tuberculosis and HIV research in South Africa
A groundbreaking partnership between the Howard Hughes Medical Institute (HHMI) and the University of KwaZulu-Natal (UKZN) in South Africa will establish an international research center focused on making major scientific contributions to the worldwide effort to control the devastating co-epidemic of tuberculosis (TB) and HIV and on training a new generation of scientists in Africa.

HIV/AIDS statistics for women and girls startling in US
In US the percentage of new AIDS cases diagnosed among women more than doubled between 1990 and 2005 (the most recent year for which data is available), increasing from 11 percent to more than 26 percent.

Microbicide promising as HIV prevention method for women
A clinical trial involving more than 3,000 women in the U.S. and southern Africa demonstrates for the first time the promise of a vaginal microbicide gel for preventing HIV infection in women.

New monkey model for HIV
By altering just one gene in HIV-1, scientists have succeeded in infecting pig-tailed macaque monkeys with a human version of the virus that has until now been impossible to study directly in animals.

Evolutionary biologist gets grant to study HIV
Dr. Sara Sawyer will use a $120,000 grant from the Foundation for AIDS Research (amFAR) to study how the HIV virus and the cells it attacks have evolved together over time. The goal of her research is to discover new targets for drugs.

Anti HIV gel shows promise in preventing HIV infection in women
An investigational vaginal gel intended to prevent HIV infection in women has demonstrated encouraging signs of success in a clinical trial conducted in Africa and the United States.

National Black HIV AIDS Awareness and Information Day
The scourge of HIV/AIDS, which continues to affect the African-American community disproportionately, highlights the importance of a comprehensive strategy to address the U.S. epidemic.

New approach to treat HIV, AIDS
Researchers at the Indiana University School of Medicine have identified a potential new target in the war on HIV/AIDS.

Pk antigen in blood raises resistance to HIV
Researchers have discovered a potentially important new resistance factor in the battle against HIV: blood types. An international team of researchers from Canadian Blood Services, The Hospital for Sick Children (SickKids) and Lund University in Sweden have discovered that certain blood types are more predisposed to contracting HIV, while others are more effective at fending it off.

Circumcision reduces HIV risk in US men
A new U.S. study has found that being circumcised significantly reduced the risk of HIV infection in heterosexual African American men known to have been exposed to the virus.

109 medicines, vaccines in development for HIV AIDS
America's pharmaceutical research companies are testing 109 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).

£15 m for South Africa in new struggle against AIDS
South Africa's revitalised drive against AIDS today received a £15 million boost which could help save millions of lives and stop the spread of HIV across the country.

Routine HIV testing fails in US
While the U.S. AIDS epidemic simmers largely unnoticed by most Americans, a failure to widely implement routine HIV testing continues to fuel its spread, HIV researchers and experts said.

A man defeated HIV virus through bone marrow transplant
An HIV-positive person, who underwent a bone marrow transplant to treat leukemia, has had undetectable HIV viral loads for almost two years. HIV-positive man was ill from leukemia and had underwent treatment by the team led by Prof. Eckhard Thiel, director of the Medical Clinic with a focus on hematology and oncology.

TIM 3 protein turns off HIV fighting T cells
In HIV-infected patients the body's immune system is unable to fight off the virus. A new study to be published online on November 10th in the Journal of Experimental Medicine shows that T cells in HIV-infected individuals express a protein called TIM-3, which inactivates their virus killing capacity.

HIV infected patients should start HAART sooner
Under current treatment guidelines, highly active antiretroviral therapy (HAART) should be considered for HIV-infected patients when their CD4+ T-cell counts fall below 350 cells per cubic millimeter (mm3).

Estimating lives lost due to delay in HIV drug use in South Africa
More than 330,000 lives were lost to HIV/AIDS in South Africa from 2000 and 2005 because a feasible and timely antiretroviral (ARV) treatment program was not implemented, assert researchers from the Harvard School of Public Health (HSPH) in a study published online by the Journal of Acquired Immune Deficiency Syndromes (JAIDS) (http://www.jaids.com/).

Antiretrovirals with TB treatment reduces mortality in HIV patients
A South African treatment study conducted by researchers in the Department of Epidemiology at the Mailman School of Public Health shows that mortality among TB-HIV co-infected patients can be reduced by a remarkable 55%, if antiretroviral therapy (ART) is provided with TB treatment at the same time.

UN hails recipients of Nobel Prize for discovering HIV
The United Nations has applauded the awarding of the 2008 Nobel Prize for Medicine to two French scientists for their discovery of HIV and for their subsequent pioneering research into the virus.

Anti inflammatory drugs linked with reduced breast cancer risk
Analysis of data from 38 studies that enrolled more than 2.7 million women – the largest of its kind – by researchers at the University of British Columbia, Vancouver Coastal Health Research Institute, and the University of Santiago de Compostela reveals that regular use of Non Steroidal Anti-Inflammatory Drugs (NSAIDs) is associated with a 12 per cent relative risk reduction in breast cancer compared to non-users.

Indian doctors can't deny HIV+, AIDS patients
India's Supreme Court has approved the Indian Govt.'s direction to all States that doctors in government and private hospitals should not refuse treatment to People Living with HIV/AIDS (PLHA).

HIV began spreading among humans between 1884 and 1924
New research indicates that the most pervasive global strain of HIV began spreading among humans between 1884 and 1924, suggesting that growing urbanization in colonial Africa set the stage for the HIV/AIDS pandemic.

Two HIV/TB global leaders announce merger talks
Formal merger negotiations were announced between two global leaders on HIV and TB: Health & Development Networks (HDN) and the International HIV/AIDS Alliance - at the XVII International AIDS Conference which concluded in Mexico on 8_August 2008. The merger will create a new joint organisation with a global mandate, which will be part of the Alliance family.

India to develop HIV AIDS vaccine soon
A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced.

HIV people not tested for tuberculosis
A mere 1% of people living with HIV/AIDS are reported to have been screened for TB, according to the most recent global data available from the World Health Organization. Health experts and activists at the International AIDS Conference are calling upon HIV/AIDS programs and international donors to ensure universal TB screening of every person who has tested positive for HIV.

HIV risk high in indian women abused by husbands
Married women in India who experience physical and sexual violence from their husbands have an increased risk of HIV infection, compared with women who are not abused by their husbands, according to a study in the August 13 issue of JAMA, a theme issue on violence and human rights.

Dr. Ramadoss to Mexico to attend AIDS Conference
Indian Health Minister Dr. Anbumani Ramadoss, Minister of Health & Family Welfare, Government of India has left for Mexico city and New York on official tour today.

WHO's new HIV AIDS guide
At the XVII International AIDS Conference in Mexico City, the World Health Organization (WHO) launched a package of priority interventions designed to help low- and middle-income countries move towards universal access to HIV/AIDS prevention, treatment, care and support.

International AIDS Society updates treatment guidelines for HIV infection
An evaluation of recent data has led to an update in the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection, according to an article in the August 6 issue of JAMA, a theme issue on HIV/AIDS.

40% higher HIV infection estimate in US
The Centers for Disease Control and Prevention (CDC) is expected soon to increase the estimate of new HIV infections in the United States by 40 percent. This highlights the need to make HIV testing a routine part of medical care and provide better funding to care for those who test positive, according to the HIV Medicine Association (HIVMA).

Genetic variation in Africans raises HIV risk
A genetic variation which evolved to protect people of African descent against malaria has now been shown to increase their susceptibility to HIV infection by up to 40 per cent, according to new research. Conversely, the same variation also appears to prolong survival of those infected with HIV by approximately two years.

OPAL Therapy cost-effective method of treating HIV
Australian researchers have unveiled a new immunotherapy technique to help prevent the progression from HIV infection to AIDS. Details of the simple, cost-effective technique are published May 2nd in the open-access journal PLoS Pathogens.

Monitoring AIDS treatment by physical signs is effective
When millions of HIV-infected people in poor countries began receiving advanced drug therapies, critics worried that patient care would suffer because few high-tech laboratories were available to guide treatments. But according to a study being published in The Lancet, these concerns are as yet unfounded.

CD16 monocyte could be a biomarker for progression of HIV
An increase in the CD163+/CD16+ monocyte subset could be a biomarker for the progression of HIV disease, according to researchers at Temple University, reported in the March issue of AIDS Research and Human Retroviruses.

HIV cases reduced in New Zealand
The New Zealand AIDS Foundation is welcoming the reduction in overall numbers of new HIV diagnoses in 2007, in particular that diagnoses among gay and bisexual men have remained equivalent to 2006 levels.

Progress in TB diagnosis and control slowing
The Global tuberculosis control 2008, released by WHO, finds that the pace of the progress to control the tuberculosis (TB) epidemic slowed slightly in 2006, the most recent year for which data were available. The new information documents a slowdown in progress on diagnosing people with TB.

HIV AIDS organisations to highlight progress and lessons learned
HIV/AIDS implementers from around the world will gather in Kampala, Uganda, from June 3-7 for the 2008 HIV/AIDS Implementers' Meeting. Recognizing the rapid expansion of HIV/AIDS programs worldwide, the focus of this year's meeting is building the capacity of local prevention, treatment, and care programs; enhancing quality; and promoting coordination among partners.

Researchers discover TRIM22 gene that blocks HIV
Researchers at the University of Alberta have discovered a gene that is able to block HIV, and in turn prevent the onset of AIDS. Stephen Barr, a molecular virologist in the Department of Medical Microbiology and Immunology, says his team has identified a gene called TRIM22 that can block HIV infection in a cell culture by preventing the assembly of the virus.

Tenofovir gel safe for daily use
A vag inal microbicide that incorporates an antiretroviral (ARV) drug normally used to treat people with HIV is safe for sexually active HIV-negative women to use every day over an extended period, suggest results of a clinical trial of tenofovir topical gel.

Anti HIV gel Tenofovir proven safe for women
An experimental anti HIV gel is safe for women to use on a daily basis, according to researchers at the University of Alabama at Birmingham (UAB) and the University of Pittsburgh School of Medicine.

Global meet on microbicides begins in India
The 4-day biannual International Microbicides 2008 Conference was inaugurated yesterday by the Indian Minister for Health & Family Welfare, Dr. Anbumani Ramadoss. Congratulating the Indian Council for Medical Research (ICMR) for organizing this important international event, the Minister particularly emphasized the need for an active participation and collaboration amongst all stakeholders in achieving the goal of developing a safe, effective, and accessible microbicide for a woman more than a man to deal with behavioral change.

GSK reduces HIV drugs prices for poor countries
GSK today announced significant new price reductions for its HIV medicines offered on a not-for-profit basis to the world's poorest countries. This reduction is the fifth time the company has made a price reduction as part of its pioneering preferential pricing policy originally introduced in 1997.

100 Aids articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
4.67